Marine Natural Products and Obesity
Material type:
- text
- computer
- online resource
- 9783039211913
- 9783039211920
- books978-3-03921-192-0
- Medicine
- 3T3-L1 cells
- adipocyte
- adipocytes
- adipogenesis
- anti-obesity drugs
- antiobesity
- Arthrospira maxima
- bioactive compound
- bioactivity
- bioactivity screening
- bisabolane-related compounds
- body fat
- brown seaweed
- cellularity
- chitosan oligosaccharide
- chlorophyll derivatives
- cholesterol metabolism
- collagen
- collagen peptide
- cyanobacteria
- diabetes
- diphlorethohydroxycarmalol (DPHC)
- double-blind
- dyslipidemia
- fat
- fatty acid metabolism
- fatty liver disease
- fucan
- glucolipid metabolism disorder
- high fat diet
- high-fat diet
- inflammation
- Ishige okamurae
- JAK2-STAT3
- label-free quantitative proteomics
- leptin
- lipolytic
- marine alga
- marine biodiscovery
- marine sponges
- mechanisms of action
- metabolite profiling
- murine pre-adipocytes
- natural compounds
- nutraceuticals
- nutrition
- obesity
- peroxisome proliferator-activated receptor gamma
- physical exercise
- PPAR?
- proliferation
- Raja kenojei
- randomized controlled trial
- skate skin
- Skate skin
- thermal proteome profiling
- uncoupling protein 1
- white adipose tissue
- whole small animal models
- zebrafish Nile red fat metabolism assay
Open Access Unrestricted online access star
Obesity and related co-morbidities are increasing worldwide and pose a serious health problem. Changes in lifestyle and diet would be the best remedies to fight obesity; however, many people will still rely on medical aid. Marine organisms have been prolific in the production of bioactive compounds for many diseases, e.g., cancer, and promise to be an excellent source for natural-derived molecules and novel nutraceuticals. Bioactive compounds with beneficial activities towards obesity have been described from diverse marine organism including marine algae, bacteria, sponges, fungi, crustaceans or fish. This Special Issue will highlight the progress in the following topics: Bioactive compounds for the treatment of obesity and obesity-related co-morbidities (diabetes, fatty liver, hyperlipidemia) from marine organisms; the isolation of novel compounds, the bioactivity screening of marine organisms and the elucidation of molecular mode of action of marine bioactive compounds.
Creative Commons https://creativecommons.org/licenses/by-nc-nd/4.0/ cc
https://creativecommons.org/licenses/by-nc-nd/4.0/
English
There are no comments on this title.